Tracking Renal Tumors After Cryoablation Evaluation (TRACE)
Tracking Renal Tumors After Cryoablation Evaluation (TRACE) Registry
Sponsor: Boston Scientific Corporation
Terminated
Boston Scientific acquisition of BTG/Galil Medical - business decision made to stop follow-up early
Other terminated trials from Boston Scientific Corporation
- Atrial Fibrillation Paroxysmal · Phase NA · Nov 2025
- Benign Prostatic Hyperplasia · Phase NA · Jul 2025
- Varicose Veins · Phase PHASE4 · Apr 2024
- Benign Biliary Strictures With Current or Prior Biliary Obstruction · Phase PHASE4 · Feb 2024
- Heart Failure NYHA Class II · Oct 2023
More terminations from Boston Scientific Corporation
This observational or N/A phase trial investigates Kidney Neoplasms and is currently terminated or withdrawn. Boston Scientific Corporation leads this study, which shows 13 recorded versions since 2010 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Feb 2024 — Jul 2024 [monthly]
Terminated
-
Dec 2021 — Feb 2024 [monthly]
Terminated
-
Sep 2021 — Dec 2021 [monthly]
Terminated
▶ Show 8 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Jul 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting
-
Mar 2019 — Jun 2020 [monthly]
Active Not Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Jul 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Scientific Corporation
For direct contact, visit the study record on ClinicalTrials.gov .